Read + Share
Amedeo Smart
Independent Medical Education
Dhir B, Meena SK, Sardana K, Sharath S, et al. Use of tofacitinib in baricitinib-refractory atopic dermatitis: An example of JAK inhibitor switching. Pediatr Dermatol 2023 Jul 26. doi: 10.1111/pde.15386.PMID: 37495552
Email
LinkedIn
Facebook
Twitter
Privacy Policy